These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 36926556)

  • 1. Functional nano-systems for transdermal drug delivery and skin therapy.
    Liu L; Zhao W; Ma Q; Gao Y; Wang W; Zhang X; Dong Y; Zhang T; Liang Y; Han S; Cao J; Wang X; Sun W; Ma H; Sun Y
    Nanoscale Adv; 2023 Mar; 5(6):1527-1558. PubMed ID: 36926556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.
    Qu F; Geng R; Liu Y; Zhu J
    Theranostics; 2022; 12(7):3372-3406. PubMed ID: 35547773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases.
    Yang D; Chen M; Sun Y; Jin Y; Lu C; Pan X; Quan G; Wu C
    Acta Biomater; 2021 Feb; 121():119-133. PubMed ID: 33285323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.
    Yu YQ; Yang X; Wu XF; Fan YB
    Front Bioeng Biotechnol; 2021; 9():646554. PubMed ID: 33855015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems.
    Myburgh J; Liebenberg W; Willers C; Dube A; Gerber M
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traversing the Skin Barrier with Nano-emulsions.
    Burger C; Shahzad Y; Brummer A; Gerber M; du Plessis J
    Curr Drug Deliv; 2017; 14(4):458-472. PubMed ID: 27557672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal Delivery of Macromolecules Using Nano Lipid Carriers.
    Kalave S; Chatterjee B; Shah P; Misra A
    Curr Pharm Des; 2021; 27(42):4330-4340. PubMed ID: 34414868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal and transdermal peptide delivery using enhancer molecules and colloidal carrier systems. Part V: Transdermal administration of insulin.
    Alyoussef Alkrad J; Neubert RHH
    Int J Pharm; 2022 Mar; 616():121511. PubMed ID: 35091007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of cold atmospheric plasma for transdermal drug delivery: a review.
    Wen X; Xin Y; Hamblin MR; Jiang X
    Drug Deliv Transl Res; 2021 Jun; 11(3):741-747. PubMed ID: 32562255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal Drug Delivery: A Step towards Treatment of Cancer.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2022; 17(3):253-267. PubMed ID: 34856914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Chemical Composition and Transdermal Delivery Systems for Topical Bio-actives in Skin Cancer.
    Halder J; Mishra A; Kar B; Ghosh G; Rath G
    Curr Top Med Chem; 2023; 23(1):31-43. PubMed ID: 36056871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases.
    Carter P; Narasimhan B; Wang Q
    Int J Pharm; 2019 Jan; 555():49-62. PubMed ID: 30448309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement strategies for transdermal drug delivery systems: current trends and applications.
    Ramadon D; McCrudden MTC; Courtenay AJ; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):758-791. PubMed ID: 33474709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Updates in Transdermal Therapeutic Systems and Their Role in Neurological Disorders.
    Yadav N; Mittal A; Ali J; Sahoo J
    Curr Protein Pept Sci; 2021; 22(6):458-469. PubMed ID: 33183199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations.
    Lunter D; Klang V; Eichner A; Savic SM; Savic S; Lian G; Erdő F
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery systems. 6. Transdermal drug delivery.
    Ranade VV
    J Clin Pharmacol; 1991 May; 31(5):401-18. PubMed ID: 2050824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of Transdermal Drug Delivery Devices and Novel Microneedle Technologies: A Historical Perspective and Review.
    Joshi N; Azizi Machekposhti S; Narayan RJ
    JID Innov; 2023 Nov; 3(6):100225. PubMed ID: 37744689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.